Clinical Trials Logo

Cicatrix clinical trials

View clinical trials related to Cicatrix.

Filter by:

NCT ID: NCT03971968 Completed - Cicatrix Clinical Trials

Observational Study for the Long-Term Effects of a Dermal Substitute on Patients With Facial Burns.

Start date: January 31, 2019
Phase:
Study type: Observational

The aim of this observational study is to investigate the long-term (between 10-20 years) results for the surgical treatment of third degree burn injury in the face and/or the neck by means of Integra® Dermal Regeneration Template. This study is an observational case-control study. The healthy skin of a comparable and/or contralateral skin-site of the face/neck serves as a comparator. The population consists of human volunteers between 18 and 75 years old with third degree full thickness burn injuries in the face and/or neck, who underwent surgical treatment with IDRT between 1998 and 2008.

NCT ID: NCT03915847 Completed - Clinical trials for Cesarean, Residual Myometrial Thickness

Evaluation of Cesarean Scar After Three Different Uterine Closure Technis

Start date: April 16, 2019
Phase: N/A
Study type: Interventional

The study compares three techniques of uterine closure on myometrium thickness at the site of uterine scar of women who underwent repeated cesarean section. Cesarean scar will be evaluated by transvaginal ultrasound six months after cesarean.

NCT ID: NCT03901417 Active, not recruiting - Acne Scars Clinical Trials

Comparison of 1550nm Fractional Laser Alone Versus in Combination With Microneedling for the Treatment of Acne Scars

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Acne scarring is an unfortunate consequence of inflammatory acne vulgaris that often leads to significant cosmetic and psychosocial impacts. Although there have been many advances in the treatment of acne scarring, it remains one of the greatest challenges in cosmetic and laser dermatology. There have been a multitude of studies establishing the efficacy of non-ablative fractional laser therapy for the treatment of atrophic acne scars, and it is widely regarded as one of the best available treatments. More recently, there has been a renewed interest in controlled, non-thermal dermal injury via microneedling devices in the treatment of atrophic acne scars. Where there is a gap in the literature, however, is in the evaluation of the combination of non-ablative fractional laser resurfacing with microneedling in the treatment of atrophic acne scars. The investigators' study will compare the safety and efficacy of using non-ablative fractional laser versus a combination of microneedling and non-ablative fractional laser for atrophic acne scars using a randomized, double-blind, split-face study. The investigators' aim is to further elucidate the pathogenesis of acne scarring and the best approaches for treatment. In doing so, the investigators will study a combination approach to this complex problem in order to better serve future patients.

NCT ID: NCT03887377 Enrolling by invitation - Scar Clinical Trials

The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

Start date: June 10, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

1. Test the ability of botulinum toxin type A, when injected into the surgical incision at the time of surgery, to decrease postoperative scar scores compared to control (normal saline) in a double-blinded randomized control trial. 2. Investigate the mechanism of BTXa effects of scar formation by measuring micro RNA profiles at two time points in the healing process.

NCT ID: NCT03887208 Completed - Scar Clinical Trials

Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells

2ABC
Start date: January 31, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is to compare clinical outcomes of patients with large scars or Cutis laxa treated with injections of autologous stromal vascular fraction cells (SVF) and adipose-derived mesenchymal stem cells (ADSC).

NCT ID: NCT03880058 Completed - Scars Clinical Trials

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

Start date: March 3, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Multicenter, double-blind study comparing SLI-F06 to vehicle formulation buffer for the improvement in scar appearance and wound strength in routine surgical excisions, as well as post-operative abdominoplasty scar appearance.

NCT ID: NCT03850119 Not yet recruiting - Hypertrophic Scar Clinical Trials

Nanofat on Wound Healing and Scar Formation

NFWHSF
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness and safety of intradermal injection of Nanofat on wound healing and scar formation.

NCT ID: NCT03842644 Completed - Scar Clinical Trials

Postoperative Skin Surface Tension Relaxing in Prevention of Facial Surgical Skin Scarring

Start date: February 16, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of early postoperative skin surface reduction in improving scar formation after facial surgery.

NCT ID: NCT03821324 Completed - Acne Scars Clinical Trials

Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring

Start date: December 11, 2018
Phase: N/A
Study type: Interventional

Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate the progress of 15 subjects requesting treatment of acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

NCT ID: NCT03795116 Completed - Fibrosis Clinical Trials

Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention

Start date: March 18, 2019
Phase: Phase 2
Study type: Interventional

Skin scarring (fibrosis) is a common complication in the wound healing process and remains a therapeutic challenge. Scar formation often occurs following injury to the skin such as surgery, trauma, and burns. The goal of this study is to evaluate the safety and efficacy of visible red light as a modality to reduce skin scarring after mini-facelift surgery. Based on laboratory data, light emitting diode-red light (LED-RL) phototherapy may lessen post-surgical skin fibrosis clinically.